Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (Beta-blockers) compared with periods that they are not taking the medication, a new study finds. If the findings ...
RECENTLY, long-lasting hypotensive agents have been described which act by blocking adrenergic neurones: of these, guanethidine 1 and bretylium 2 have been widely used clinically.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback